Order Article Reprints

Nguyen T-M, Ngo T-H, Truong A-Q, Vu D-H, Le D-C, Vu N-B, Can T-N, Nguyen H-A, Phan T-P, Van Bambeke F, et al. Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Pharmaceutics. 2021; 13(4):456. https://doi.org/10.3390/pharmaceutics13040456

Nguyen, Thu-Minh, Thu-Hue Ngo, Anh-Quan Truong, Dinh-Hoa Vu, Dinh-Chi Le, Ngan-Binh Vu, Tuyet-Nga Can, Hoang-Anh Nguyen, Thu-Phuong Phan, Françoise Van Bambeke, and et al. 2021. "Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease" Pharmaceutics 13, no. 4: 456. https://doi.org/10.3390/pharmaceutics13040456

Nguyen, T.-M., Ngo, T.-H., Truong, A.-Q., Vu, D.-H., Le, D.-C., Vu, N.-B., Can, T.-N., Nguyen, H.-A., Phan, T.-P., Van Bambeke, F., Vidaillac, C., & Ngo, Q.-C. (2021). Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Pharmaceutics, 13(4), 456. https://doi.org/10.3390/pharmaceutics13040456